Inflammatix, Inc.

Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis. This test has not yet been cleared or approved by the FDA, nor has it been CE marked. Inflammatix is establishing partnerships with diagnostic instrument, companion therapeutic and commercial distribution companies across the globe.